Cofoe Medical Joins Consortium to Establish Hangzhou AI Venture Fund

Stock News02-13

Cofoe Medical Technology Co., Ltd. (301087.SZ) has announced the signing of a partnership agreement with Guangzhou Danlu Equity Investment Management Co., Ltd., Hangzhou High-tech Venture Capital Management Co., Ltd., Shenzhen Xinhao Xinxing Venture Capital Co., Ltd., Hangzhou Gongshu Industrial Fund Co., Ltd., and Sequoia Yuhui (Xiamen) Equity Investment Partnership to jointly establish the Hangzhou Gongshu District Danlu Talent AI Venture Investment Fund. The total committed capital from all partners amounts to 80 million yuan, with Cofoe Medical contributing 20 million yuan from its own funds, representing a 25.00% stake. The fund's investment focus aligns with Cofoe Medical's core business operations. This investment aims to leverage the resources and investment management expertise of all parties involved to enhance the company's investment returns and capital operation capabilities, expand its industrial layout, and promote sustainable development, while ensuring the steady growth of its main business.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment